1Bosuquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med, 1990, 323: 1033-1039.
2Wenzel SE, Schwartz LB, Langmack EL, et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med, 1999, 160: 1001-1008.
3Douwes J, Gibson P, Pekkanen J, et al. Non-eosinophilic asthma: importance and possible mechanisms. Throax, 2002, 57: 643-648.
4Shi HZ, Xiao CQ, Zhong D, et al. Effect of inhaled interleukin-5 on airway hyperreacitvity and eosinophilia in asthmatics. Am J Respir Critical Care Med, 1998, 157: 204-209.
5Leckie MJ, ten Brinke A, Knan J, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinphils, airway hyperresponsiveness and the late asthmatic response. Lancet, 2000, 356: 2144-2148.
6Flood-Page PT, Menzies-Gow AN, Kay AB, et al. Eosinophil′s role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med, 2003, 167: 199-204.
7Kips JC, O′Connor BJ, Langley SJ, et al. Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study. Am J Respir Crit Care Med, 2003, 167: 1655-1659.
8Mauser PJ, Pitman A, Witt A, et al. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am Rev Respir Dis, 1993, 148: 1623-1627.
9Hogan SP, Matthaei KI, Young JM, et al. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5. J Immunol, 1998, 161: 1501-1509.
